// App-Quantinova.ai

: Telomere Length Is Associated with Epigenetic Programming in CLL and Is a Superior Predictor of Clinical Outcome with the Ability to Bifurcate Patients with the Same CLL-IPI Score

Researchers

Presenter

  • Kevin Norris

Principal Investigators

  • Christopher C. Oakes

  • Brian Giacopelli

  • Tait D. Shanafelt

  • Neil E. Kay

  • Kari G. Chaffee

  • Christopher Fegan

  • Duncan M Baird

  • Chris Pepper

Medical Centers

  • Institute of Cancer & Genetics, Cardiff University, Cardiff, Wales, United Kingdom

  • Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • The Ohio State Univerisity, Columbus, OH

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Department of Health Sciences Research, Mayo Clinic, Rochester, MN

  • Cardiff and Vale University Health Board, Cardiff,

  • Division of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom

  • Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved